ALSIENI, M.; BABADER, R.; KENANY, S.; ABDULGADER, S.; ALAFIF, R.; ALAHMADI, A.; ALOUFI, A.; FALLATAH, E.; ALQAHTANI, R.; IZALDIN, A. The prevalence Regarding the Use of Glucagon-like Peptide-1 (GLP-1) Agonists as an Obesity Treatment among Adult Patients at King Abdulaziz University Medical Services Center, Jeddah, Saudi Arabia: a Descriptive Cross-Sectional Study: The prevalence of Glucagon-like Peptide-1 (GLP-1) Agonists use as an Obesity Treatment among adults in Saudi Arabia. Journal of King Abdulaziz University: Medical Sciences, [S. l.], v. 31, n. 2, 2024. Disponível em: https://journals.kau.edu.sa/index.php/MedSci/article/view/2412. Acesso em: 22 jan. 2025.